“The Evolution of Lymphangioleiomyomatosis (LAM) Management: From Hormonal Manipulation to Targeted Inhibition of the Mammalian Target of Rapamycin (mTOR) Pathway”. Research, Society and Development 14, no. 4 (April 18, 2025): e4614448656. Accessed February 7, 2026. https://rsdjournal.org/rsd/article/view/48656.